ARABIA, GENNARINA
 Distribuzione geografica
Continente #
NA - Nord America 2.746
EU - Europa 1.502
AS - Asia 1.089
SA - Sud America 78
OC - Oceania 21
AF - Africa 8
Continente sconosciuto - Info sul continente non disponibili 7
Totale 5.451
Nazione #
US - Stati Uniti d'America 2.617
IT - Italia 739
SG - Singapore 647
CN - Cina 288
DE - Germania 203
SE - Svezia 165
GB - Regno Unito 130
CA - Canada 105
FI - Finlandia 99
IN - India 64
BR - Brasile 60
FR - Francia 30
ES - Italia 27
HK - Hong Kong 25
NL - Olanda 24
MX - Messico 23
AU - Australia 20
RO - Romania 18
JP - Giappone 14
PL - Polonia 13
UA - Ucraina 10
PT - Portogallo 8
TR - Turchia 8
BD - Bangladesh 7
EU - Europa 7
PE - Perù 7
CL - Cile 6
AT - Austria 5
CZ - Repubblica Ceca 5
IE - Irlanda 5
IR - Iran 5
MY - Malesia 5
DK - Danimarca 4
GR - Grecia 4
IL - Israele 4
KZ - Kazakistan 4
CH - Svizzera 3
TW - Taiwan 3
VN - Vietnam 3
ZA - Sudafrica 3
AE - Emirati Arabi Uniti 2
BE - Belgio 2
CO - Colombia 2
ID - Indonesia 2
IQ - Iraq 2
KE - Kenya 2
LT - Lituania 2
RU - Federazione Russa 2
AR - Argentina 1
CY - Cipro 1
DZ - Algeria 1
EC - Ecuador 1
ET - Etiopia 1
HN - Honduras 1
KR - Corea 1
MD - Moldavia 1
MK - Macedonia 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PH - Filippine 1
PK - Pakistan 1
SI - Slovenia 1
SN - Senegal 1
TH - Thailandia 1
UZ - Uzbekistan 1
VE - Venezuela 1
Totale 5.451
Città #
Chandler 531
Singapore 294
Santa Clara 221
Milan 214
Princeton 178
Lawrence 177
Munich 166
Wilmington 115
London 108
Chicago 103
Ottawa 89
Ashburn 74
Helsinki 65
Des Moines 55
Catanzaro 48
Rome 36
Guangzhou 30
Turku 30
Shanghai 29
Boardman 28
Casalnuovo Di Napoli 28
Los Angeles 22
Hong Kong 19
Norwalk 17
Brooklyn 15
Florence 15
Naples 15
Redwood City 15
Shenzhen 14
Beijing 13
Hanover 13
New York 12
Pune 11
Timisoara 10
Lamezia Terme 9
Madrid 9
Mexico City 9
San Francisco 9
The Dalles 9
Altavilla Milicia 8
São Paulo 8
Chennai 7
Phoenix 7
Redmond 7
Sydney 7
Warsaw 7
Wuhan 7
Columbus 6
Lima 6
Orta Nova 6
Rochester 6
Seattle 6
Tokyo 6
Zungri 6
Adelaide 5
Ankara 5
Atlanta 5
Bari 5
Boston 5
Cagliari 5
Falls Church 5
Horia 5
Jinan 5
Olomouc 5
Palakkad 5
Puteaux 5
Wuxi 5
Xi'an 5
Zhengzhou 5
Acerra 4
Ann Arbor 4
Augusta 4
Barcelona 4
Berlin 4
Bologna 4
Cosenza 4
Curitiba 4
Fuzhou 4
Jiaxing 4
Kuala Lumpur 4
Misterbianco 4
Montreal 4
Mountain View 4
Nanjing 4
Nola 4
Padova 4
Paris 4
Quanzhou 4
San Jose 4
Xochimilco 4
Argusto 3
Aversa 3
Birmingham 3
Blumenau 3
Catania 3
Charlotte 3
Council Bluffs 3
Dallas 3
Dublin 3
Floridia 3
Totale 3.144
Nome #
Magnetic Resonance Parkinsonism Index for evaluating disease progression rate in progressive supranuclear palsy: A longitudinal 2-year study 400
Age at onset influences neurodegenerative processes underlying PD with levodopa-induced dyskinesias 165
A new MR imaging index for differentiation of progressive supranuclear palsy-parkinsonism from Parkinson's disease. 146
Combined Use of DAT-SPECT and Cardiac MIBG Scintigraphy in Mixed Tremors 89
Proceedings - 2017 IEEE International Conference on Healthcare Informatics, ICHI 2017 69
Differential microRNAs expression profile in coronary thrombi from patients with no-reflow after primary PCI 53
Myocardial I-123-MIBG scintigraphy for differentiation of Lewy bodies disease from FTD 50
Apomorphine-induced reorganization of striato-frontal connectivity in patients with tremor-dominant Parkinson's disease 50
Abnormal prefrontal gray matter in Parkinson’s disease patients with levodopa-induced dyskinesia: a combined voxel-based morphometry and cortical thickness study 48
Incidental evidence of hypointensity in brain grey nuclei on routine MR imaging: when to suspect a neurodegenerative disorder? 48
Different hippocampal subfields involvement in AD and PDD: a multimodal 3T MRI study 45
Microstructural changes of normal-appearing white matter in Vascular Parkinsonism 43
A case of spinocerebellar ataxia type 17 (SCA 17) 43
Cerebellar involvement in essential tremor with and without resting tremor: A Diffusion Tensor Imaging study 43
Alterations of putaminal shape in de novo Parkinson’s disease 42
Diffusion tensor imaging study of cerebellum in essential tremor with and without resting tremor 39
The embodiment of language in tremor-dominant Parkinson's disease patients 39
Structural connectivity differences in essential tremor with and without resting tremor. 38
Brain iron deposition in essential tremor: a quantitative 3T MRI study 38
Structural connectivity differences in motor network between tremor-dominant and nontremor Parkinson's disease. 37
Gradient echo MRI sequences for putaminal hypointensity in multiple system atrophy: the best choice of time echo 37
Alterations of putaminal shape in de novo Parkinsos's disease 36
Identification of one novel mutation in GRN gene associated with frontotemporal dementia 36
Anti-GAD associated inflammatory myopathy presenting with dropped head syndrome 36
Hippocampal impairment in patients with Essential Tremor: Hippocampal changes in ET 36
Voluptuary Habits and Clinical Subtypes of Parkinson's Disease: The FRAGAMP Case-Control Study 35
Midbrain hemiatrophy and nigral rarefaction in a patient with hemiparkinsonism-hemiatrophy syndrome. 35
Aging does not induce caudate nuclei and thalami hypointensities in healthy subjects: a 3.0 Tesla MR imaging study 35
Head tremor associated with unilateral rest tremor: ET, PD or other? 35
Magnetic Resonance Imaging Biomarkers Distinguish Normal Pressure Hydrocephalus From Progressive Supranuclear Palsy 35
Clinical, electrophysiological, and imaging study in essential tremor-Parkinson's disease syndrome 34
CADA-computer-aided DaTSCAN analysis. 34
Effect of aging on MR measures differentiating progressive supranuclear palsy from Parkinson disease 34
Thalamic neurometabolic alterations in tremulous Parkinson's disease: A preliminary proton MR spectroscopy study. 33
Blink reflex recovery cycle distinguishes essential tremor with resting tremor from de novo Parkinson’s disease: An exploratory study 33
Magnetic Resonance Parkinsonism Index and midbrain to pons ratio: which index better distinguishes Progressive Supranuclear Palsy patients with a low degree of diagnostic certainty from patients with Parkinson disease? 33
In vivo evidence for decreased scyllo-inositol levels in the supplementary motor area of patients with Progressive Supranuclear Palsy: A proton MR spectroscopy study 33
REM-Sleep Behavior Disorder in Patients With Essential Tremor: What Is Its Clinical Significance? 33
Guillain-Barré syndrome following BNT162b2 COVID-19 vaccine 33
Age at onset influences neurodegenerative processes underlying PD with levodopa-induced dyskinesias. 32
Fronto-parietal overactivation in patients with essential tremor during Stroop task 32
Adult-onset leukodystrophy and dystonic tremor: a case report 32
Imaging counterpart of postural instability and vertical ocular dysfunction in patients with PSP: A multimodal MRI study. 32
Hyper-religiosity and visual hallucinations in a patient with frontotemporal dementia carrying a double variant in GRN gene 31
Refining initial diagnosis of Parkinson's disease after follow-up: A 4-year prospective clinical and magnetic resonance imaging study. 31
Intraventricular tumour presenting as progressive supranuclear palsy-like phenotype 31
Diffusion tensor imaging of substantia nigra in Parkinson’s disease: a 3 Tesla study 31
Superior cerebellar peduncle is differently damaged in progressive supranuclear palsy phenotypes 31
Methodologies of speech analysis for neurodegenerative diseases evaluation 31
Chronic VIM Stimulation improves bradikynesia in Parkinson disease 31
Wine drinking and essential tremor: a possible protective role. 30
Hormonal replacement therapy in women with Parkinson disease and levodopa-induced dyskinesia: A crossover trial 30
Track density imaging in progressive supranuclear palsy: a pilot study 30
Machine learning on brain MRI data for differential diagnosis of Parkinson's disease and Progressive Supranuclear Palsy 30
Cardiac MIBG scintigraphy in Primary Progressive Freezing Gait 30
Tremor pattern differentiates drug-induced resting tremor from Parkinson disease. 30
Measurement of third ventricle width for differentiation of progressive supranuclear palsy from Parkinson’s disease and multiple system atrophy 30
Blink reflex recovery cycle distinguishes essential tremor with resting tremor from de novo Parkinson's disease 30
Evidence of excess of glutamate + glutamine in thalamus of essential tremor: a proton MR spectroscopy study 30
Deep Brain Stimulation in a Patient with Isolated Mixed Tremor 29
Association study between the LINGO1 gene and Parkinson's disease in the Italian population. 28
Neuroanatomical correlates of dystonic tremor: a cross-sectional study 28
Diffusivity of cerebellar hemispheres enables discrimination of cerebellar or parkinsonian multiple system atrophy from progressive supranuclear palsy-richardson syndrome and Parkinson disease 28
The midbrain to pons ratio: a simple and specific MRI sign of progressive supranuclear palsy. 28
Heart rate variability in patients with essential tremor: A cross sectional study. 28
Blink reflex recovery cycle in patients with essential tremor associated with resting tremor. 28
Intraventricular tumor presenting as progressive supranuclear palsy-like phenotype 28
Myocardial MIBG scintigraphy for differentiating Lewy bodies disease from frontotemporal dementia 28
Magnetic Resonance Parkinsonism Index in PSP and in a large cohort of patients with Parkinson’s disease 28
Rest tremor pattern differentiates drug-induced parkinsonism from Parkinson's disease 28
ANXA1 mutation analysis in Italian patients with early onset PD 27
Sex and gender differences in movement disorders: Parkinson's disease, essential tremor, dystonia and chorea 27
Personality biomarkers of pathological gambling: A machine learning study 27
Anti-GM1 ganglioside antibodies in Parkinson's disease. 27
Prefrontal thickening in PD with levodopa-induced dyskinesias: new evidence from cortical thickness measurement 27
The motor inhibition system in Parkinson's disease with levodopa-induced dyskinesias 27
Brain iron deposition in essential tremor: a quantitative 3-Tesla magnetic resonance imaging study. 27
Deep brain stimulation in the treatment of Parkinson's disease. Our experience 27
Prefrontal dysfunction in Parkinson’s disease patients with levodopa-induced dyskinesia during FMRI motor task 27
Clinical, electrophysiological and MRI findings in essential tremor with and without resting tremor 27
Non-motor symptoms in essential tremor-Parkinson disease (ET-PD) syndrome 27
Cardiac MIBG scintigraphy for differentiation of the primary progressive freezing gait from PD 27
Idiopathic REM sleep behaviour disorder: a premotor phase of Parkinson’s disease? 27
Observing the emergence of neural dysfuntions during peak-dose levodopa-induced dyskinesias in Parkinson’s disease: an FNIRS study 27
Mixed tremors with integrity of nigrostriatal system: a clinical and DAT-SPECT follow-up study 27
Age at onset of Parkinson's disease influences neurodegenerative processes underlying levodopa-induced dyskinesias 27
Body weight influences pharmacokinetics of levodopa in Parkinson's disease. 26
Magnetic Resonance Parkinsonism Index in the clinically undefined parkinsonian syndromes 26
Asymmetry index on SPECT/MRI image fusion in patients with different subtypes of essential tremor 26
Cortical volume and folding abnormalities in Parkinson's disease patients with pathological gambling 26
Reduced thalamic volume in PD with REM sleep behaviour disorder: a voxel-based morphometry study 26
Heart rate variability in patients with essential tremor: a cross sectional study 26
The placebo effect on resting tremor in Parkinson’s disease: an electrophysiological study 26
Association of tau gene polymorphism with Parkinson's disease. 26
Clinical and imaging features of essential tremor-Parkinson disease (ET-PD) syndrome 26
Primary lateral sclerosis mimicking atypical parkinsonism 26
Progressive supranuclear palsy-parkinsonism evolving form Parkinson’s disease: a follow-up study 25
Resting-state brain networks in Parkinson's disease with levodopa-induced dyskinesias 25
Processing graspable object images and their nouns is impaired in Parkinson's disease patients 25
Magnetic Resonance Parkinsonism Index for evaluating disease progression rate in progressive supranuclear palsy: A longitudinal 2-year study 25
Totale 3.897
Categoria #
all - tutte 73.488
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 73.488


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021176 18 19 1 5 18 2 17 32 36 10 14 4
2021/2022516 17 3 7 104 80 15 9 120 52 33 69 7
2022/20231.569 363 24 36 155 182 154 14 123 259 109 104 46
2023/2024807 143 98 60 63 49 163 28 44 16 51 47 45
2024/20252.273 305 202 139 100 137 303 109 124 274 50 166 364
2025/202628 28 0 0 0 0 0 0 0 0 0 0 0
Totale 5.545